VetImmune® Resources for Veterinarians
From this page you can download all published research papers on the use of Polyprenyl Immunostimulant™, our order forms (US and International) as well as product information insert, brochure, and dosage card, all in one convenient location.
Clinical Trials run by Sass & Sass, Inc and other research groups are also listed below.
Order forms
Download this form if you are a veterinarian or a cat guardian located in the US.
Download this form if you are a veterinarian or a cat guardian located outside the US.
Documentation
Polyprenyl Immunostimulant™ package insert.
Feline Rhinotracheitis (FRV) treatment brochure.
Polyprenyl Immunostimulant™ Dosage card for Rhinotracheitis.
Polyprenyl Immunostimulant™ - 2021 FIP Trial information.
Research publications
Legendre AM, Bartges JW. 2009, JFMS, 11, 624-626
Legendre AM et al. Front Vet Sci, February 14, 2017
Legendre AM et al. Front Vet Sci, February 27. 2017
Polyprenyl Immunostimulant™ clinical trials
All clinical trials and are run by Sass & Sass, Inc., the manufacturer, and other research groups. You may request more detailed information from Sass & Sass, Inc. by email.
Past, current, and planned clinical trials.
All clinical trials and are run by Sass & Sass, Inc., the manufacturer, and other research groups. You may request more detailed information from Sass & Sass, Inc. by email.
• Double-blinded, placebo-controlled clinical trials of the efficacy of Polyprenyl Immunostimulant™ in feline rhinotracheitis.University of Tennessee-Knoxville. Dr. A.M. Legendre, Principal Investigator.
Status: Completed.
Results published at http://journal.frontiersin.org/article/10.3389/fvets.2017.00024/full
• Field study of efficiency of Polyprenyl Immunostimulant™ in naturally occurring cases of non-effusive FIP. University of Tennessee-Knoxville. Dr. A.M. Legendre, Principal Investigator.
Status: Completed.
Results published at https://www.frontiersin.org/articles/10.3389/fvets.2017.00007/full
• Field safety study of Polyprenyl Immunostimulant™. University of Tennessee-Knoxville. Dr. A.M. Legendre, Principal Investigator.
Status: Completed.
Results published at http://journal.frontiersin.org/article/10.3389/fvets.2017.00024/full
• Clinical safety study of ocular topical application of Polyprenyl Immunostimulant™. University of Tennessee-Knoxville. Dr. D. VanHorn Hendrix, Principal Investigator.
Status: Completed.
Results presented at the meeting of the American College of Veterinary Ophthalmologists in 2017.
• Field efficacy study of Polyprenyl Immunostimulant™ in herpetic keratitis. University of Tennessee-Knoxville. Dr. D. VanHorn Hendrix, Principal Investigator.
Status: Will open soon. Eligibility: ophthalmology specialists only. The enrollment information will follow.
• Case studies in cats with chronic rhinotracheitis treated with Polyprenyl Immunostimulant™.
Status: On-going.